Etofenamate formulation

Details Etofenamate formulation Etofenamate formulation

1986-03-20

1988-03-15

Brown, J. R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514 57, 514 63, 514163, 514234, 514356, 514506, 514549, 514552, 514724, 514762, 514825, 514886, 514943, 514965, 424 78, 424 79, 424 80, 424 81, 424 82, 424 83, 424154, A61K 31135, A61K 31715, A61K 31695, A61K 3161

Patent

active

047313846

ABSTRACT:
The invention relates to topical antiinflammatory medicament formulations which also have analgesic activity and contain 2-(2-hydroxyethoxy)-ethyl N-(.alpha.,.alpha.,.alpha.,-trifluoro-m-tolyl) anthranilate as the active ingredient and an adjuvant which is preferably a triglyceride.

REFERENCES:
Arzneimittelforschung, 27, (I), Special Edition 6b, p. 1300, (1977).
Rote Liste, 1982, p. 452, Editio Cantor, Aulendorf/Wurtt., DE., No. 05448: "Rheumon".
Merck Index 9th ed p. 684-5075, 1976.
Chem Absts. 92:379e, 1980; 97:13809s; 97:138310k; 97:138311; 97; 1982 and 100:6096r, 1984.

Affiliated with

Also associated with

Rating

Etofenamate formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Etofenamate formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Etofenamate formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1926757